Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 31.95-10.0912.99274.74-63.19

What is the latest Core EBITDA Growth ratio of BAL PHARMA ?

The latest Core EBITDA Growth ratio of BAL PHARMA is 31.95 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202431.95
Mar2023-10.09
Mar202212.99
Mar2021274.74
Mar2020-63.19

How is Core EBITDA Growth of BAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 31.95
Positive
Mar2023 -10.09
Negative
Mar2022 12.99
-95.27
Mar2021 274.74
Positive
Mar2020 -63.19 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹180.9 Cr 8.1% -10.4% -3.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,132.0 Cr 2.2% -5.8% 22.9% Stock Analytics
DIVIS LABORATORIES ₹149,254.0 Cr 4.1% -7% 52% Stock Analytics
CIPLA ₹116,123.0 Cr 1.3% -4.8% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,573.0 Cr 2.2% -10.9% -0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹97,966.9 Cr 7% -0.2% 27.5% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

8.1%

-10.4%

-3.3%

SENSEX

2.8%

-3.1%

9%


You may also like the below Video Courses